PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 32 filers reported holding PHARMACYTE BIOTECH INC in Q2 2022. The put-call ratio across all filers is 6.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243 | +57.8% | 116 | +114.8% | 0.00% | – |
| Q2 2023 | $154 | -1.9% | 54 | 0.0% | 0.00% | – |
| Q1 2023 | $157 | -45.1% | 54 | -44.9% | 0.00% | – |
| Q4 2022 | $286 | – | 98 | +81.5% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 54 | -96.9% | 0.00% | – |
| Q2 2022 | $4,000 | – | 1,734 | +2889.7% | 0.00% | – |
| Q1 2022 | $0 | – | 58 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 58 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,217,828 | $3,045,000 | 0.44% |
| Ayrton Capital LLC | 153,130 | $383,000 | 0.36% |
| Shay Capital LLC | 662,337 | $1,656,000 | 0.27% |
| EQUITEC PROPRIETARY MARKETS, LLC | 258,694 | $647,000 | 0.09% |
| Anson Funds Management LP | 193,400 | $484,000 | 0.05% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 44,944 | $112,000 | 0.00% |
| Jump Financial, LLC | 10,300 | $26,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 30,400 | $76,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,763 | $5,000 | 0.00% |